巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Inhibrx

    INBX
    17.490
    0.190
    1.10%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Inhibrx - 延遲價格・最後更新於 29/09 8:28
    最高位
    17.550
    最低位
    16.710
    開市價
    --
    前收市價
    17.300
    成交量(千)
    35.16
    成交額(百萬)
    5.41
    買入
    13.770
    賣出
    21.900
    每手股數
    --
    市值(百萬)
    683.12
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    47.900 - 7.670
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Inhibrx
    證券代碼
    INBX.US
    所屬板塊
    Biotechnology
    公司業務
    Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.
    發行量
    39025644
    公司總部
    11025 N. Torrey Pines Road, Suite 200
    公司網址
    http://www.inhibrx.com
    公司電話
    +1 858 795-4220
    暫無內容

    關於

    Inhibrx(INBX.US)所屬的行業板塊為Biotechnology。
    Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.
    詳細公司背景可參考: http://www.inhibrx.com